CHE - Chemed Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$475.00
DETAILS
HIGH:
$475.00
LOW:
$475.00
MEDIAN:
$475.00
CONSENSUS:
$475.00
UPSIDE:
8.11%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 48,693 | $18.4M | 0.1% | -10,477 | DECREASED |
| Cooperman | 42,909 | $16.2M | 0.0% | -16,564 | DECREASED |
| Dalio | 5,062 | $1.9M | 0.0% | -6,217 | DECREASED |
| Laffont | 1,644 | $621,005 | 0.1% | +286 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-18 | WALSH GEORGE J III | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | Mount John Meredith Jr. | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | McCarthy Eileen P | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | LINDELL ANDREA R | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | Heaney Christopher J | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | GRACE PATRICK P | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-18 | DeLyons Ron | director | A-Award | 386 | $440.77 | $170K |
| 2026-05-08 | GRACE PATRICK P | director | SELL | 60 | $425.78 | $26K |
| 2026-05-01 | MCNAMARA KEVIN J | director, officer: president and CEO | SELL | 2,000 | $421.13 | $842K |
| 2026-03-27 | MCNAMARA KEVIN J | director, officer: president and CEO | SELL | 1,500 | $369.37 | $554K |
| 2026-03-12 | MCNAMARA KEVIN J | director, officer: president and CEO | SELL | 2,000 | $403.18 | $806K |
| 2026-02-13 | MCNAMARA KEVIN J | director, officer: president and CEO | A-Award | 5,114 | -- | -- |
| 2026-02-13 | LEE SPENCER S | officer: executive vice president | M-Exempt | -- | $469.56 | -- |
| 2026-02-13 | LEE SPENCER S | officer: executive vice president | F-InKind | 154 | $469.56 | $72K |
| 2026-02-13 | LEE SPENCER S | officer: executive vice president | A-Award | 960 | -- | -- |
| 2026-02-13 | HUTTON THOMAS C | director, officer: vice president | M-Exempt | 160 | -- | -- |
| 2026-02-13 | Wherley Joel L | officer: CEO - Vitas Healthcare | A-Award | 1,142 | -- | -- |
| 2026-02-13 | Wherley Joel L | officer: CEO - Vitas Healthcare | M-Exempt | 220 | -- | -- |
| 2026-02-13 | Wherley Joel L | officer: CEO - Vitas Healthcare | M-Exempt | -- | $469.56 | -- |
| 2026-02-13 | Wherley Joel L | officer: CEO - Vitas Healthcare | F-InKind | 80 | $469.56 | $38K |
| 2026-02-13 | Witzeman Michael D | officer: VP & Chief Financial Officer | M-Exempt | -- | $469.56 | -- |
| 2026-02-13 | Witzeman Michael D | officer: VP & Chief Financial Officer | M-Exempt | 333 | -- | -- |
| 2026-02-13 | MCNAMARA KEVIN J | director, officer: president and CEO | M-Exempt | -- | $469.56 | -- |
| 2026-02-13 | MCNAMARA KEVIN J | director, officer: president and CEO | F-InKind | 1,192 | $469.56 | $560K |
| 2026-02-13 | MCNAMARA KEVIN J | director, officer: president and CEO | M-Exempt | 2,187 | -- | -- |